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Objective: We present a prenatal diagnosis and molecular cytogenetic characterization of low-level true
mosaicism for trisomy 21 using uncultured amniocytes.
Case report: A 35-year-old woman presented with a borderline-positive result of noninvasive prenatal
testing for trisomy 21. She underwent amniocentesis at 18 weeks of gestation, which revealed a kar-
yotype of 47,XY,þ21(5)/46,XY(53). Repeat amniocentesis at 22 weeks of gestation revealed a karyotype of
47,XY,þ21(6)/46,XY(26). Array comparative genomic hybridization (aCGH) analysis on uncultured
amniocytes revealed mosaic levels of 10% to 15% for trisomy 21. Interphase ﬂuorescence in situ hybrid-
ization (FISH) analysis on uncultured amniocytes revealed a mosaic level of 21.7% (28/129 cells) for
trisomy 21. Following genetic counseling and detailed ultrasound examination, the parents decided to
continue the pregnancy. The pregnancy was carried to term, and a normal 3664-g male baby was
delivered. The cord blood lymphocytes had a karyotype of 47,XY,þ21(2)/46,XY(38). Postnatal interphase
FISH analysis of urine detected no trisomy 21 in all 39/39 urinary cells. The neonate was phenotypically
normal at age 7 months.
Conclusion: Low-level true mosaicism for trisomy 21 can be associated with a favorable fetal outcome.
aCGH and interphase FISH analyses on uncultured amniocytes are useful for rapid conﬁrmation of low-
level true mosaicism for trisomy 21 at repeated amniocentesis.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Molecular cytogenetic techniques, such as array comparative
genomic hybridization (aCGH) and interphase ﬂuorescence in situ
hybridization (FISH), for rapid positive conﬁrmation of trisomy
mosaicism have been well described [1e4]. Here, we report an
additional case involving trisomy 21 with a low-level mosaicism.s and Gynecology, Mackay
Road, Taipei 10449, Taiwan.
).
bstetrics & Gynecology. Published bFollowing genetic counseling of low-level mosaicism for trisomy 21,
the pregnancy was carried to term, and a healthy baby was deliv-
ered with no phenotypic abnormality at age 7 months. Our expe-
rience may be helpful for genetic counseling for low-level
mosaicism for trisomy 21 at amniocentesis.Case Report
A 35-year-old primigravid woman presented with a borderline-
positive result of noninvasive prenatal testing for trisomy 21. Her
husband was 35 years of age, and there was no family history ofy Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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18 weeks of gestation, which revealed a karyotype of 47,XY,þ21(5)/
46,XY(53). The prenatal ultrasound ﬁndings were unremarkable.
Repeat amniocentesis was performed at 22 weeks of gestation,
which revealed a karyotype of 47,XY,þ21(6)/46,XY(26). Among 32
colonies of cultured amniocytes, six colonies (18.75%) had the kar-
yotype of 47,XY,þ21, whereas the remaining 26 colonies (81.25%)
had the karyotype of 46,XY. aCGH analysis using Roche ISCA Plus
Cytogenetic Array (Roche, Basel, Switzerland) on uncultured
amniocytes showed a result of arr 21p11.2q22.3 (9,668,085e
48,111,085)2.20 (Figure 1), indicating a 10% to 15% mosaicism for
trisomy 21. Interphase FISH analysis on uncultured amniocytes
revealed a mosaic level of 21.7% (28/129 cells) for trisomy 21
(Figure 2). The amniocytes in the control case had a level of 3.1% (4/
127 cells) mosaicism for trisomy 21 according to FISH analysis.
Polymorphic DNA marker analysis using DNA extracted from un-
cultured amniocytes and parental blood excluded uniparental dis-
omy21, and theparental karyotypeswerenormal. Following genetic
counseling and detailed ultrasound examination, the parents
decided to continue the pregnancy, which was carried to term. A
healthy 3664-g male baby was delivered. The cord blood lympho-
cytes had a karyotype of 47,XY,þ21(2)/46,XY(38). Postnatal inter-
phase FISH analysis of the neonate urine at age 1month detected no
trisomy21 in all 39/39urinarycells. Theneonatewasphenotypically
normal at age 7 months during pediatric follow-ups.Figure 1. Array comparative genomic hybridization analysis on uncultured amniocytes sho
mosaicism for trisomy 21. (A and B) Chromosome zoom-in views.Discussion
In patients with Down syndrome, approximately 90% to 95% of
individuals have free trisomy for chromosome 21, 2% to 4% of in-
dividuals have unbalanced Robertsonian translocations involving
chromosome 21, and 2% to 4% of individuals have mosaicism [5,6].
However, various population studies showed that low-level
mosaicism for trisomy 21 may be unrecognized and under-
diagnosed [6]. For example, Devilin and Morrison [7] reported that
only 37.5% of individuals with mosaic trisomy 21 were detected by
clinical examinations as compared with nearly 100% of individuals
with non-mosaic Down syndrome. Bornstein et al [8] reported that,
in cases of amniocentesis, 13.7% (17/124) of mosaic trisomy 21 cases
exhibited abnormal ultrasound, 27.2% (135/496) of non-mosaic
trisomy 21 cases exhibited abnormal ultrasound, and 14.1% (70/
496) of normal controls exhibited abnormal ultrasound. Therefore,
genetic amniocentesis due to advanced maternal age may unex-
pectedly detect mosaic trisomy 21, and the detection of low-level
mosaicism for trisomy 21 at amniocentesis under such a circum-
stance can cause a difﬁcult dilemma for doctors and parents.
We previously reported rapid positive conﬁrmation of trisomy
21 mosaicism at amniocentesis by interphase FISH using uncul-
tured amniocytes [1e3], butmost cases were terminated because of
mosaic trisomy 21. However, the present case had low-level
mosaicism for trisomy 21 at amniocentesis, but was carried towed a result of arr 21p11.2q22.3 (9,668,085e48,111,085)2.20, indicating a 10% to 15%
Figure 2. Interphase ﬂuorescence in situ hybridization analysis on uncultured
amniocytes using a 21q11.2-speciﬁc BAC probe RP11-91N21 (15,964,910e16,121,996)
[hg 19] (FITC, spectrum green) and a 21q21.2-speciﬁc BAC probe RP11-89M24
(16,722,068e16,897,672) [hg 19] (Texas red, spectrum red) shows (A) a normal dis-
omy 21 cell with two green signals and two red signals and (B) an aberrant trisomy
21 cell with three green signals and three red signals. BAC ¼ bacterial artiﬁcial chro-
mosome; FITC ¼ ﬂuorescein isothiocyanate.
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low-level mosaic trisomy 21 detected by amniocentesis can be
associated with a favorable outcome. This information is especially
helpful in genetic counseling of parents who wish to continue the
pregnancy following a diagnosis of mosaic trisomy 21 at amnio-
centesis. Various reports showed a signiﬁcantly positive correlation
between the percentage of mosaicism and the severity of the
phenotype, and inverse correlation between overall survival and
the percentage of mosaicism for trisomy 21 [6,9e11]. Therefore,
rapid positive conﬁrmation of low-level mosaic trisomy 21 by aCGH
and interphase FISH using uncultured amniocytes at repeated
amniocentesis is useful, as presented in this case.The present case and our previous reports [1,2] showed that
uncultured amniocytes have higher frequency of containing tri-
somy 21 cells relative to lymphocytes in fetuses with mosaic tri-
somy 21, and accordingly, interphase FISH on uncultured
amniocytes will provide more accurate information regarding the
percentage of trisomy 21 cells as compared to blood lymphocytes
acquired by cord blood sampling. The same is true in buccal cells.
Papavassiliou et al [9] observed that buccal cells had a signiﬁcantly
higher frequency of trisomy 21 as compared to lymphocytes in
patients with mosaic trisomy 21 (48.06% ± 3.44% vs.
301.13% ± 3.99%). We suggest that, in cases of mosaic trisomy 21 at
amniocentesis, molecular cytogenetic characterization of uncul-
tured amniocytes is more useful than cord blood sampling, because
the mosaic level of trisomy 21 in lymphocytes is usually lower than
uncultured amniocytes.
In summary, we demonstrated that low-level mosaic trisomy 21
at amniocentesis can be associated with a favorable fetal outcome,
and aCGH and interphase FISH analyses on uncultured amniocytes
are useful for rapid conﬁrmation of low-level true mosaicism for
trisomy 21 at repeated amniocentesis.Conﬂicts of interest
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